Approvals only move when the evidence packet reaches the payer rule in time.
This control plane makes intake pressure, payer requirements, evidence gaps, and denial blockers visible before a prior-auth case becomes lost reimbursement or a patient-delay problem.
Clear peer-review rationale and conservative-treatment evidence first so denial risk does not cascade into missed reimbursement.
Musculoskeletal
2 days left · Attach failed conservative-treatment timeline before payer nurse review.Specialty Pharmacy
4 days left · Route missing infusion start date attestation to clinician queue.Radiology
1 days left · Escalate missing ordering rationale so the peer-review request is not auto-denied.Prior Authorization Evidence Router turns payer-rule ambiguity into an approval-safe decision packet.
Revenue cycle, utilization review, clinical operations, product, and executive teams get one readable view before evidence gaps, payer-rule mismatches, or deadline pressure create denial risk.
For non-technical leaders
Shows which approvals are exposed, what reimbursement or patient-access risk is building, and who owns the next move.
For technical and ops teams
Frames the data contract: intake cases, evidence lane, payer rules, approval posture, owners, SLA pressure, and verification gates.
For GTM and product teams
Makes the commercial story concrete: reduced denial exposure, faster packet repair, and safer embedded approval workflows without live PHI.
Model the approval lane
Capture case context, payer, service line, owner, urgency, and the approval audience before work spreads into spreadsheets.
Map rule to evidence
Connect payer requirements to the exact packet, blocker, and proof owner needed to keep the case approval-safe.
Route the decision
Escalate the highest-risk approvals with a next action leaders, operators, and customer-facing teams can all understand.
Risk, owner, proof, next action.
Risk is visible
Every surface names the operating exposure instead of hiding behind a generic dashboard or AI label.
Ownership is explicit
Each route points to the accountable lane, role, committee, or operator group responsible for closing the gap.
Proof is packaged
Representative, synthetic data turns the product promise into a reviewable evidence packet without exposing sensitive systems.
Action is board-readable
The final output is a decision narrative: what changed, why it matters, what to do next, and what remains unresolved.
Which approvals are most likely to slip next.
| Case | Packet | Owner | Days Left | Risk |
|---|---|---|---|---|
| Blue Harbor Health PA-1018 Musculoskeletal | Imaging + PT history + surgeon note | Utilization Review | 2 | critical |
| North River Advantage PA-1042 Specialty Pharmacy | Lab trend + prescribing note + benefits verification | Pharmacy Ops | 4 | watch |
| SummitCare PPO PA-1097 Radiology | Ordering note + symptom history + prior treatment record | Revenue Cycle | 1 | critical |
| Union State Health Plan PA-1126 Behavioral Health | Diagnosis record + treatment plan + progress note | Clinical Intake | 6 | watch |
| Vertex Family Health PA-1161 Cardiology | Diagnostic note + symptom log + device order | Care Navigation | 8 | low |